Navigation Links
Pew Applauds Introduction of Bipartisan Antimicrobial Data Collection Act
Date:5/8/2013

WASHINGTON, May 8, 2013 /PRNewswire-USNewswire/ -- The Pew Charitable Trusts today applauded Senators Kirsten Gillibrand (D-NY), Dianne Feinstein (D-CA), and Susan Collins (R-ME), for introducing the Antimicrobial Data Collection Act, which would require the U.S. Food and Drug Administration, or FDA, to report more information on the annual sales of antibiotics used among industrial farm animals. The bipartisan bill would also give the agency a deadline to finalize policies proposed last year to eliminate the use of antibiotics for growth promotion purposes in meat production.

"This bill is critical to helping us understand how antibiotic overuse on industrial farms is affecting human health," says Laura Rogers , director of Pew's effort to reduce antibiotic overuse in food animal production. "While decades of science clearly show that these practices breed drug-resistant bacteria that can infect us, we need to know more about the scope of the problem. Unfortunately, the Senate Health, Education, Labor and Pensions Committee recently missed an opportunity to enhance transparency about antibiotic sales in meat production in the Animal Drug User Fee Act. But we commend Senators Gillibrand, Collins and Feinstein for their bipartisan leadership and urge the Senate to swiftly pass this legislation."

The bill introduced by the three senators includes several provisions to require FDA to report antibiotic sales publicly, comprehensively, and predictably. Under the bill, the agency's reports on these sales would be broken down by dosage form (in feed, in water, or by injection), marketing status (that is, whether they are available over the counter or by veterinary order), and indication of whether the drugs are important in human medicine. FDA would be required to publish the reports by a deadline set each year. The agency issued its 2009 sales report on Dec. 9, 2010, its 2010 report on Oct. 31, 2011, and its 2011 report on Feb. 6, 2013.

In addition, within 180 days of its enactment, the bill would require FDA to finalize a set of policies aimed at eliminating the use of antibiotics for making food animals grow faster. Nearly 220,000 Americans, including leading health advocates such as Pew, have asked FDA to close loopholes in these policy documents and to publish them quickly. Pew has also urged the agency to "issue binding regulations that will further restrict the way antibiotics are used in food animal production."

In the House, Representatives Henry Waxman (D-CA) and Louise Slaughter (D-NY) on Feb. 26, 2013, introduced the Delivering Antimicrobial Transparency in Animals Act of 2013 (H.R. 820), which also requires FDA to report more detailed antibiotic sales and information on use in food animals.

The Pew Charitable Trusts is driven by the power of knowledge to solve today's most challenging problems. Pew applies a rigorous, analytical approach to improve public policy, inform the public, and stimulate civic life.


'/>"/>
SOURCE The Pew Charitable Trusts
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CHPA Applauds Governor Mike Pence and the Passage of SB 496
2. Lupus Foundation of Florida Applauds Support for Biosimilars Legislation
3. Medical Device Manufacturing Coalition Applauds Passage of Medical Device Tax Repeal Amendment
4. CHPA Applauds New Mexico Adoption Of House Bill 146
5. Watson Applauds GPhA Study Demonstrating $1 Trillion in Prescription Drug Savings from Generic Medicines
6. Mylan Applauds Study Highlighting $1 Trillion in Savings for U.S. Health Care System Due to Generic Drugs Over Past Decade
7. CRN Applauds Introduction Of Designer Anabolic Steroid Control Act
8. ADVENTRX Applauds Inclusion of Rare Diseases Provisions in the FDA Safety and Innovation Act
9. Mylan Applauds Signing of Landmark "Food and Drug Administration Safety and Innovation Act"
10. American Academy of Pain Medicine Applauds FDA Action to Enhance Patient Safety on Prescribing Opioids; Offers AAPM Safe Opioid Prescribing Course as Educational Model
11. Novation Applauds FDAs Unique Device Identification Rule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ZIONA SCIENCE PARK , Israel ... company Kadimastem (TASE: KDST) announced today the signing of a memorandum ... between the companies. The synergy between the companies will assist in ... as a worldwide leader in innovative treatment for severe diseases in ... ...
(Date:12/7/2016)... 7, 2016  Organovo Holdings, Inc. (NASDAQ: ... focused on delivering scientific and medical breakthroughs using ... and Chief Executive Officer Keith Murphy ... December 14, 2016 at 1:00 p.m. Eastern Time ... yet familiar with the Company, an informational video ...
(Date:12/7/2016)... The global  blood screening ... USD 3.9 billion by 2024, based on a ... growth of the market is attributed to the ... by the market players. Demand for blood screening ... rising awareness about transfusion-transmitted diseases, and technological developments ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... AlignLife clinics nationwide are giving back ... not fortunate enough to receive bountiful gifts wrapped tightly under a Christmas Tree. ... the children of the world. , In exchange for generous donations, customers will receive ...
(Date:12/7/2016)... ... 07, 2016 , ... Sharon Kleyne, host of the nationally syndicated radio program, ... Voice of America, declared on her radio program in November 2016 the need to ... these bullies attack leaders in corporate America, they are trying to take advantage of ...
(Date:12/7/2016)... Phoenix, Arizona (PRWEB) , ... December 07, 2016 , ... ... Juvederm®, Just in Time For The Holiday Party Season. Save Up To 33% Off ... and Laser Salon is providing the Phoenix Valley with Delightful Deals on ...
(Date:12/7/2016)... ... December 07, 2016 , ... The medical profession is well aware that heart ... major study analyzing heart attacks among 138,602 people recorded a 35% higher number of ... would all agree of course–no time of year is a good time for a ...
(Date:12/7/2016)... (PRWEB) , ... December 07, ... ... Technologies, announced its newest portable bioelectronic medicine device WellnessPro Plus for consumers ... Plus substantially enhances the WellnessPro platform by expanding the treatment modalities available ...
Breaking Medicine News(10 mins):